Arylsulfatase A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Arylsulfatase A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Arylsulfatase A (ARSA) is a lysosomal hydrolase that catalyzes the desulfation of cerebroside sulfate. Deficiency causes metachromatic leukodystrophy (MLD), a devastating demyelinating disease. This enzyme plays a critical role in maintaining the lipid composition of myelin sheaths throughout the central and peripheral nervous systems. [@mld2018]
Overview
Structure
ARSA requires a unique post-translational modification for catalytic activity:
Formylglycine (FGly) cofactor: Generated by the formylglycine-generating enzyme (FGE) at a conserved cysteine motif (C/S-X-P-X-R)
Active site: FGly coordinates sulfate ester hydrolysis
Homodimer formation: Two ARSA subunits associate for optimal activity
Glycosylation: N-linked glycans target the enzyme to lysosomes
The crystal structure reveals a compact α/β fold with the active site located in a deep pocket, accessible to substrate cerebroside 3-sulfate.
Normal Function
Enzyme Activity
Hydrolyzes cerebroside 3-sulfate (sulfatide) to galactocerebroside
Essential for proper myelin lipid metabolism
Maintains sulfatide homeostasis in myelin-producing cells
Brain Function
Supports oligodendrocyte function and survival
Enables normal myelination during development
Maintains myelin integrity throughout life
Regulates lipid raft composition in myelin membranes
Expression Pattern
ARSA shows specific expression patterns:
Oligodendrocytes: High expression in myelin-producing cells
[Neurons](/entities/neurons): Moderate expression throughout the brain
Cerebroside sulfatide metabolism in AD.J Neurosci Res. 2019. PMID: 30536542(https://pubmed.ncbi.nlm.nih.gov/30536542/)
ARSA mutations and phenotype correlation.Hum Mutat. 2017. PMID: 28229538(https://pubmed.ncbi.nlm.nih.gov/28229538/)
Enzyme therapy for MLD.Neurology. 2021. PMID: 34089012(https://pubmed.ncbi.nlm.nih.gov/34089012/)
Background
The study of Arylsulfatase A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.